Currently holds positions in Adynxx Inc and Syndax Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Chairman of the Board | Adynxx Inc | None - |
Independent Chairman of the Board | Syndax Pharmaceuticals Inc | Dec. 1, 2008 - |
Director | Euthymics Bioscience Inc | April 4, 2006 - Jan. 1, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2022-09-16 | 2022-09-16 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
6,556
-8.0%
23.43153,625 USD |
6,556 -8.0% | 23.43 | 153,625 USD | |
2022-09-16 | 2022-09-16 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
5,419
-6.7%
23.43126,982 USD |
5,419 -6.7% | 23.43 | 126,982 USD | |
2022-09-16 | 2022-09-15 |
Syndax Pharmaceuticals Inc
(SNDX)
|
PS Planned sale |
66,840
-46.9%
24.201,617,381 USD |
66,840 -46.9% | 24.20 | 1,617,381 USD | |
2021-04-22 | 2021-04-22 |
Syndax Pharmaceuticals Inc
(SNDX)
|
B Purchase |
13,967
+47.6%
14.11197,077 USD |
13,967 +47.6% | 14.11 | 197,077 USD |